ARTICLE | Finance

Back for more

Tallying Vivo's recent exits as VC raises $428M for eighth fund

January 5, 2015 8:00 AM UTC

About three years after closing its last fund, Vivo Capital (formerly Vivo Ventures) has come back for more. The firm raised $428 million for an eighth fund, according to a December SEC filing.

Vivo invests primarily in U.S. therapeutics and medical device companies in late-stage development, and in revenue-generating healthcare companies in greater China, with some small investments in public therapeutics companies. ...